Sublingual immunotherapy reduces soluble HLA-G and HLA-A,-B,-C serum levels in patients with allergic rhinitis

International Immunopharmacology

Volumn 9, Issue 2, 2009, Pages 253-257

  Ciprandi, Giorgio ^a   Contini, Paola ^a   Pistorio, Angela ^b   Murdaca, Giuseppe ^a   Puppo, Francesco ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b G GASLINI INSTITUTE   (Italy)

Author keywords

Allergic rhinitis; Pollens; sHLA A, B, C; sHLA G; Sublingual immunotherapy

Indexed keywords

BIOLOGICAL MARKER; GAMMA INTERFERON; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA G ANTIGEN; INTERLEUKIN 4; POLLEN ANTIGEN;

ADULT; ALLERGIC RHINITIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HLA SYSTEM; HUMAN; IMMUNOTHERAPY; MALE; POLLEN ALLERGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SUBLINGUAL IMMUNOTHERAPY; SYMPTOM; TREATMENT DURATION; VISUAL ANALOG SCALE;

ADMINISTRATION, SUBLINGUAL; ADULT; ALLERGENS; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-C ANTIGENS; HUMANS; MALE; MIDDLE AGED; RHINITIS, ALLERGIC, SEASONAL;

EID: 58249138536     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2008.11.009     Document Type: Article

References (35)

1. Romagnani S. Biology of human Th1 and Th2 cells. J Clin Immunol 15 (1995) 121-129
2. Umetsu D.T., and DeKruyff R.H. The regulation of allergy and asthma. Immunol Rev 212 (2006) 238-255
3. Ciprandi G., Fenoglio D., Cirillo I., Vizzaccaro A., Ferrera A., Tosca M.A., et al. Induction of interleukin 10 by sublingual immunotherapy for house dust mites: a preliminary report. Ann Allergy Asthma Immunol 95 (2005) 38-44
4. Carosella E.D., Moreau P., Aractingi S., and Rouass-freiss. HLA-G: a shield against inflammatory aggression. Trends Immunol 10 (2001) 553-555
5. Kanai T., Fujii T., Kozuma S., Yamashita T., Miki A., Kikuchi A., et al. Soluble HLA-G influences the release of cytokines from allogeneic peripheral blood mononuclear cells in culture. Mol Hum Reprod 7 (2001) 195-200
6. Pistoia V., Morandi F., Wang X., and Ferrone S. Soluble HLA-G: are they clinically relevant?. Semin Cancer Biol 17 (2007) 469-479
7. Tahan F., and Patiroglu T. Plasma soluble human leukocyte antigen G levels in asthmatic children. Int Arch Allergy Immunol 141 (2006) 213-216
8. Ciprandi G., Colombo B.M., Contini P., Cagnati P., Pistorio A., Puppo P., et al. Soluble HLA-G and HLA-A,-B,-C serum levels in patients with allergic rhinitis. Allergy 63 10 (2008) 1335-1338
9. Van Rood J.J., van Leeuwen A., and van Santen M.C.T. Anti HL-A2 inhibitor in normal human serum. Nature 226 (1970) 366-367
10. Rebmann VPfeiffer K., Pässler M., Ferrone S., Maier S., Weiss E., and Grosse-Wilde H. Detection of soluble HLA-G molecules in plasma and amniotic fluid. Tissue Antigens 53 (1999) 14-22
11. Puppo FScudeletti M., Indiveri F., and Ferrone S. Serum HLA class I antigens: markers and modulators of an immune response?. Immunol Today 16 (1995) 124-127
12. Puppo F., Contini P., Ghio M., Brenci S., Scudeletti M., Filaci G., et al. Soluble human MHC class I molecules induce soluble Fas ligand secretion and trigger apoptosis in activated CD8+ Fas(CD95)+ T lymphocytes. Int Immunol 12 (2000) 195-203
13. Spaggiari G.M., Contini P., Carosio R., Arvigo M., Ghio M., Oddone D., et al. Soluble HLA class I molecules induce natural killer cell apoptosis through the engagement of CD8. Evidence for a negative regulation exerted by CD94/NKG2A complex and KIR2D. Blood 99 (2002) 1706-1714
14. Passalacqua G., and Durham S.R. Allergic rhinitis and its impact on asthma update: allergen immunotherapy. J Allergy Clin Immunol 119 (2007) 881-891
15. Wilson D.R., Torres L.I., and Durham S.R. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy 60 (2005) 4-12
16. Calamita Z., Saconato H., Bronhara Pelà A., and Nagib Atallah A. Efficacy of Sublingual immunotherapy in asthma. Systematic review of randomized clinical trials. Allergy 61 (2006) 1162-1172
17. Cox L.S., Linnemann D.L., Nolte H., Weldon D., Finegold I., and Nelson H.S. Sublingual immunotherapy: a comprehensive review. J Allergy Clin Immunol 117 (2006) 1021-1035
18. Cosmi L., Santarlasci V., Angeli R., Liotta F., Maggi L., Frosali F., et al. Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-γ- and interleukin-10-production. Clin Exp Allergy 36 (2006) 261-272
19. Ciprandi G., Fenoglio D., Cirillo I., Vizzaccaro A., Ferrera A., Tosca M.A., et al. Induction of interleukin 10 by sublingual immunotherapy for house dust mites: a preliminary report. Ann Allergy Asthma Immunol 95 (2005) 38-44
20. Savolainen J., Jacobsen L., and Valovirta E. Sublingual immunotherapy in children modulates allergen-induced in vitro expression of cytokine mRNA in PBMC. Allergy 61 (2006) 1184-1190
21. Bousquet J., Khaltaev N., Cruz A.A., Denburg J., Fokkens W.J., Togias A., et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 Update (in collaboration with the World Health Organization, GA2LEN and AllerGen). Allergy 63 Suppl. 86 (2008) 8-160
22. Chalmers T.C., Smith Jr. H., Blackburn B., Silverman B., Schroeder B., Reitman D., et al. A method for assessing the quality of a randomized control trial. Control Clin Trials 2 (1981) 31-49
23. Bousquet P.J., Combescure C., Neukirch F., Klossek J.M., Mechin H., Daures J.P., et al. Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines. Allergy 62 (2007) 367-372
24. Rebmann V., Lemaoult J., Rouas-Freiss N., Carosella E.D., and Grosse-Wilde H. Report of the wet workshop for quantification of soluble HLA-G in Essen, 2004. Hum Immunol 66 (2005) 853-863
25. Russo C., Pellegrino M.A., and Ferrone S. A double-determinant immunoassay with monoclonal antibodies to the HLA-A, B, C complex. Transpl Proc 15 66 (1983)
26. Bachert C., Van kempen M., and Van Cauwenberge P. Regulation of proinflammatory cytokines in seasonal allergic rhinitis. Int Arch Allergy Immunol 118 (1999) 375-379
27. Ishitani A., and Geraghty D.E. Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II molecules. Proc Natl Acad Sci U S A 89 (1992) 3947-3951
28. Fujii T., Ishitani T., and Geraghty D.E. A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4. J Immunol 153 (1994) 5516-5524
29. Le Friec, Laupeze B., Fardel O., Sebti Y., Pangault C., Guilloux V., et al. Soluble HLA-G inhibits human dendritic cell-triggered allogeneic T-cell proliferation without altering dendritic differentiation and maturation processes. Hum Immunol 64 (2003) 752-761
30. Contini P., Ghio M., Poggi A., Filaci G., Indiveri F., Ferrone S., et al. Soluble human HLA-A, -B, -C, and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation. Eur J Immunol 33 (2003) 125-134
31. Rizzo R., Mapp C., Melchiorri L., Maestrelli P., Visentin A., Ferretti S., et al. Defective production of soluble HLA-G molecules by peripheral blood monocytes in patients with asthma. J Allergy Clin Immunol 115 (2005) 508-513
32. Jutel M., Akdis M., Blaser K., and Akdis C.A. Mechanism of allergen specific immunotherapy - T cell tolerance and more. Allergy 61 (2006) 796-807
33. Savolainen J., Nieminem K., Laaksonen K., Laiho T., Jacobsen L., Lahesmaa R., et al. Allergen-induced in vitro expression of IL-18, SLAM and GATA-3 mRNA in PBMC during sublingual immunotherapy. Allergy 62 (2007) 949-953
34. Kapasi K., Albert S.E., Yie S.M., Zavazava N., and Librach C.L. HLA-G has a concentration-dependent effect on the generation of an allo-CTL response. Immunology 101 (2000) 191-200
35. Ciprandi G., Contini P., Fenoglio D., Sormani M.P., Negrini S., Puppo F., et al. Relationship between soluble HLA-G and HLA-A,-B,-C serum levels and IFN-gamma production after sublingual immunotherapy in patients with allergic rhinitis. Hum Immunol 69 7 (2008) 409-413